The Centers for Disease Control and Prevention (CDC) has updated its recommendations regarding COVID-19 vaccinations for ...

Immunocompromised people who are age 65 or older should get a second dose of the 2024-2025 COVID-19 vaccine, according to the latest recommendations from the Centers for Disease Control and Prevention ...

Immunocompromised adults or those who are older than 65 should get a second dose of the latest COVID-19 vaccine, the Centers ...

U.S. health officials are recommending that people 50 and older get a shot against bacteria that can cause pneumonia and ...

All adults aged 50 and older should receive a vaccine against bacteria that can cause pneumonia and meningitis, federal ...

The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract ...

With Pfizer’s stock down sharply, an activist investor is pushing for CEO Albert Bourla to improve performance.

The mRNA Revolution When the COVID-19 pandemic struck, the world's medical community initially prepared for a disaster of the scale of the Spanish Flu, which struck during WW1 and killed 50 million ...

GPN Vaccines is thrilled to announce the appointment of Dr. Bruce Forrest as its new Chief Scientific Officer (CSO). Bruce has over 30 years of global leadership experience in Pharmaceutical ...

Canada will not be providing Novavax for the 2024/25 season, leaving those who would have preferred an alternative to the ...

GSK filed two lawsuits at the US District of Delaware on 15 October saying that Moderna’s mRNA vaccine product Spikevax ...

COVID-19 vaccination rates have varied significantly based on partisanship and socioeconomic factors, with Democrats getting ...